Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125414991 | 12541499 | 1 | I | 201605 | 20160628 | 20160708 | 20160708 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-054411 | BRISTOL MYERS SQUIBB | 57.55 | YR | M | Y | 0.00000 | 20160708 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125414991 | 12541499 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 15 MG, QD | N | 21436 | 15 | MG | TABLET | QD | |||||
| 125414991 | 12541499 | 2 | SS | TERCIAN /00759301/ | CYAMEMAZINE | 1 | Oral | UNK | 0 | ORAL DROPS | |||||||||
| 125414991 | 12541499 | 3 | SS | TRIHEXYPHENIDYLE | TRIHEXYPHENIDYL | 1 | Oral | UNK | U | 0 | |||||||||
| 125414991 | 12541499 | 4 | SS | LITHIUM. | LITHIUM | 1 | Oral | 400 MG, QD | U | 0 | 400 | MG | QD | ||||||
| 125414991 | 12541499 | 5 | C | INSULIN | INSULIN NOS | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125414991 | 12541499 | 1 | Bipolar disorder |
| 125414991 | 12541499 | 2 | Product used for unknown indication |
| 125414991 | 12541499 | 3 | Product used for unknown indication |
| 125414991 | 12541499 | 4 | Product used for unknown indication |
| 125414991 | 12541499 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125414991 | 12541499 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125414991 | 12541499 | Abnormal behaviour | |
| 125414991 | 12541499 | Anhedonia | |
| 125414991 | 12541499 | Anxiety | |
| 125414991 | 12541499 | Apathy | |
| 125414991 | 12541499 | Cognitive disorder | |
| 125414991 | 12541499 | Disorientation | |
| 125414991 | 12541499 | Encephalopathy | |
| 125414991 | 12541499 | Hallucination | |
| 125414991 | 12541499 | Iatrogenic injury | |
| 125414991 | 12541499 | Myoclonus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125414991 | 12541499 | 1 | 201603 | 0 |